SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-22-000050
Filing Date
2022-11-10
Accepted
2022-11-10 07:02:38
Documents
43
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q siox-20220930.htm   iXBRL 10-Q 908603
2 EX-31.1 a09302210qsioxexhibit311.htm EX-31.1 11009
3 EX-32.1 a09302210qsioxexhibit321.htm EX-32.1 7145
  Complete submission text file 0001636050-22-000050.txt   3440641

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20220930.xsd EX-101.SCH 21641
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20220930_cal.xml EX-101.CAL 33622
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20220930_def.xml EX-101.DEF 108322
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20220930_lab.xml EX-101.LAB 320952
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20220930_pre.xml EX-101.PRE 188451
37 EXTRACTED XBRL INSTANCE DOCUMENT siox-20220930_htm.xml XML 405155
Mailing Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036
Business Address 1501 BROADWAY 12TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 221374859
SIC: 2834 Pharmaceutical Preparations